14โ€“17 Sept 2025
Palace of Culture and Science
Europe/Warsaw timezone

Session

S20 Emerging Bioprinting Platforms for Musculoskeletal Tissue Engineering

15 Sept 2025, 15:30
Kisielewski

Kisielewski

Conveners

S20 Emerging Bioprinting Platforms for Musculoskeletal Tissue Engineering

  • Francesca Diletta Spagnuolo (Trinity College Dublin)
  • Eben Alsberg (University of Illinois Chicago)

Presentation materials

There are no materials yet.

  1. Gabriela S. Kronemberger (Trinity College Dublin)
    15/09/2025, 15:30
    invited lecture

    Lesions in the menisci are frequently related to sports injuries and dramatically increase the risk of developing osteoarthritis. It is estimated that 1.5 million meniscal repairs are performed annually in the United States and Europe, representing one of the most common clinical procedures performed by orthopaedic surgeons. In the field of tissue engineering there is increased interest in the...

    Go to contribution page
  2. Daniel Kelly (Trinity College Dublin)
    15/09/2025, 15:50
    invited lecture

    Our musculoskeletal system has a limited capacity for repair. This has led to increased interest in the development of tissue engineering and biofabrication strategies for the regeneration of musculoskeletal tissues such as bone, ligament, tendon, meniscus and articular cartilage. This invited talk will demonstrate how different musculoskeletal tissues, specifically cartilage, bone and...

    Go to contribution page
  3. Max Wirth (Trinity College Dublin)
    15/09/2025, 16:10
    podium presentation

    Articular cartilage (AC) transmits large mechanical loads in synovial joints. This tissueโ€™s properties derive from its unique composition and structure, which consists of glycosaminoglycans and type II collagen arranged into arcade-like structures [1]. AC has a limited capacity for regeneration, hence damage here typically leads to the development of osteoarthritis, a disease impacting the...

    Go to contribution page
  4. Akihiro Nishiguchi (National Institute for Materials Science)
    15/09/2025, 16:20
    podium presentation

    Introduction: Three dimensional (3D) bioprinting provides a wide avenue to design complex and customized constructs for tissue regeneration, disease modelling, and drug testing applications. Bioink formulations in 3D bioprinting usually lack the presence of micrometre-sized and interconnected pores, resulting in reduce cell viability and prevent biological communications with host tissues,...

    Go to contribution page
  5. Chen Ye (1.University Hospital Carl Gustav Carus and Faculty of Medicine at TUD Dresden University of Technology. 2. Center for Translational Bone,)
    15/09/2025, 16:30
    podium presentation

    Abstract
    Introduction
    Osteosarcoma (OS), the most common malignant bone tumor, poses significant clinical challenges due to its aggressive progression and limited therapeutic options for metastatic disease[1]. Current preclinical models fail to replicate the mechanical and biochemical complexity of the bone microenvironment[2]. This study explores melt electrowriting (MEW) technology to...

    Go to contribution page
  6. Marina Volpi (Warsaw University of Technology)
    15/09/2025, 16:40
    podium presentation

    The myotendinous junction (MTJ) is a highly specialized interface that connects skeletal muscle to tendon, enabling the transmission of contractile forces and ensuring efficient biomechanical performance of the musculoskeletal system. Functionally, the MTJ plays a pivotal role in maintaining structural continuity between two developmentally distinct tissuesโ€”muscle and tendonโ€”while withstanding...

    Go to contribution page
  7. Taeeun Lim (Chonnam National University)
    15/09/2025, 16:50
    podium presentation

    Abstract
    Skeletal muscle plays a critical role in voluntary movement and metabolic regulation, and its dysfunction is implicated in the onset and progression of musculoskeletal and systemic diseases. While interest in the development of therapeutics for skeletal muscle disorders is steadily increasing, conventional in vitro models are limited by low throughput, the complexity of platform...

    Go to contribution page
Building timetable...